Evidence continues to build for the long-term efficacy of PD-1—targeting immunotherapies in melanoma, including fresh data indicating when patients can stop taking the drugs and still maintain a ...
Locoregional therapy for hepatocellular carcinoma before transplant: Impact on tumor necrosis, tumor recurrence, and long-term survival. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results